Özal Adiyeke, Onur Sarban, Ergün Mendeş, Hilal Akça, Engin İhsan Turan, Barış Demirkol, Mehmet Akif Özgül, Funda Gümüş Özcan
{"title":"双频谱指数监测:优化硬质支气管镜检查中的麻醉。","authors":"Özal Adiyeke, Onur Sarban, Ergün Mendeş, Hilal Akça, Engin İhsan Turan, Barış Demirkol, Mehmet Akif Özgül, Funda Gümüş Özcan","doi":"10.5578/tt.202403938","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study investigates the application of bispectral index (BIS) monitoring in rigid bronchoscopy to enhance anesthetic delivery and patient outcomes, a topic that remains underexplored.</p><p><strong>Materials and methods: </strong>A retrospective analysis of 155 patients undergoing elective rigid bronchoscopy under general anesthesia was conducted. Patients were divided into BIS-monitored and conventional anesthesia groups. Inclusion criteria were adults aged over 18 years with American Society of Anesthesiologists (ASA) physical status I-IV.</p><p><strong>Result: </strong>No significant demographic differences were found between the groups. The BIS group showed significant reductions in propofol usage (231.40 ± 74.63 mg vs. 190.19 ± 91.83 mg, p= 0.003) and prednol dosage (94.27 ± 42.56 mg vs. 79.71 ± 18.97 mg, p= 0.020). Remifentanil administration approached statistical significance (56.99 ± 34.69 mcg vs. 45.36 ± 36.75 mcg, p= 0.055).</p><p><strong>Conclusions: </strong>No significant demographic differences were found between the groups. The BIS group showed significant reductions in propofol usage (231.40 ± 74.63 mg vs. 190.19 ± 91.83 mg, p= 0.003) and prednol dosage (94.27 ± 42.56 mg vs. 79.71 ± 18.97 mg, p= 0.020). Remifentanil administration approached statistical significance (56.99 ± 34.69 mcg vs. 45.36 ± 36.75 mcg, p= 0.055).</p>","PeriodicalId":519894,"journal":{"name":"Tuberkuloz ve toraks","volume":"72 3","pages":"191-196"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bispectral index monitoring: Optimizing anesthesia in rigid bronchoscopy.\",\"authors\":\"Özal Adiyeke, Onur Sarban, Ergün Mendeş, Hilal Akça, Engin İhsan Turan, Barış Demirkol, Mehmet Akif Özgül, Funda Gümüş Özcan\",\"doi\":\"10.5578/tt.202403938\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This study investigates the application of bispectral index (BIS) monitoring in rigid bronchoscopy to enhance anesthetic delivery and patient outcomes, a topic that remains underexplored.</p><p><strong>Materials and methods: </strong>A retrospective analysis of 155 patients undergoing elective rigid bronchoscopy under general anesthesia was conducted. Patients were divided into BIS-monitored and conventional anesthesia groups. Inclusion criteria were adults aged over 18 years with American Society of Anesthesiologists (ASA) physical status I-IV.</p><p><strong>Result: </strong>No significant demographic differences were found between the groups. The BIS group showed significant reductions in propofol usage (231.40 ± 74.63 mg vs. 190.19 ± 91.83 mg, p= 0.003) and prednol dosage (94.27 ± 42.56 mg vs. 79.71 ± 18.97 mg, p= 0.020). Remifentanil administration approached statistical significance (56.99 ± 34.69 mcg vs. 45.36 ± 36.75 mcg, p= 0.055).</p><p><strong>Conclusions: </strong>No significant demographic differences were found between the groups. The BIS group showed significant reductions in propofol usage (231.40 ± 74.63 mg vs. 190.19 ± 91.83 mg, p= 0.003) and prednol dosage (94.27 ± 42.56 mg vs. 79.71 ± 18.97 mg, p= 0.020). Remifentanil administration approached statistical significance (56.99 ± 34.69 mcg vs. 45.36 ± 36.75 mcg, p= 0.055).</p>\",\"PeriodicalId\":519894,\"journal\":{\"name\":\"Tuberkuloz ve toraks\",\"volume\":\"72 3\",\"pages\":\"191-196\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tuberkuloz ve toraks\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5578/tt.202403938\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberkuloz ve toraks","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5578/tt.202403938","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
导言:本研究探讨了双频谱指数(BIS)监测在硬质支气管镜检查中的应用,以提高麻醉效果和患者预后,而这一课题仍未得到充分探索:对 155 名在全身麻醉下接受择期硬质支气管镜检查的患者进行了回顾性分析。患者被分为 BIS 监测组和常规麻醉组。纳入标准为 18 岁以上、美国麻醉医师协会(ASA)身体状况 I-IV 级的成年人:结果:两组之间没有发现明显的人口统计学差异。BIS 组的异丙酚用量(231.40 ± 74.63 mg vs. 190.19 ± 91.83 mg,p= 0.003)和泼尼松用量(94.27 ± 42.56 mg vs. 79.71 ± 18.97 mg,p= 0.020)明显减少。瑞芬太尼用量接近统计学意义(56.99 ± 34.69 微克 vs 45.36 ± 36.75 微克,p= 0.055):结论:两组之间没有发现明显的人口统计学差异。BIS 组的异丙酚用量(231.40 ± 74.63 mg vs. 190.19 ± 91.83 mg,p= 0.003)和泼尼松用量(94.27 ± 42.56 mg vs. 79.71 ± 18.97 mg,p= 0.020)明显减少。瑞芬太尼用量接近统计学意义(56.99 ± 34.69 微克 vs 45.36 ± 36.75 微克,p= 0.055)。
Bispectral index monitoring: Optimizing anesthesia in rigid bronchoscopy.
Introduction: This study investigates the application of bispectral index (BIS) monitoring in rigid bronchoscopy to enhance anesthetic delivery and patient outcomes, a topic that remains underexplored.
Materials and methods: A retrospective analysis of 155 patients undergoing elective rigid bronchoscopy under general anesthesia was conducted. Patients were divided into BIS-monitored and conventional anesthesia groups. Inclusion criteria were adults aged over 18 years with American Society of Anesthesiologists (ASA) physical status I-IV.
Result: No significant demographic differences were found between the groups. The BIS group showed significant reductions in propofol usage (231.40 ± 74.63 mg vs. 190.19 ± 91.83 mg, p= 0.003) and prednol dosage (94.27 ± 42.56 mg vs. 79.71 ± 18.97 mg, p= 0.020). Remifentanil administration approached statistical significance (56.99 ± 34.69 mcg vs. 45.36 ± 36.75 mcg, p= 0.055).
Conclusions: No significant demographic differences were found between the groups. The BIS group showed significant reductions in propofol usage (231.40 ± 74.63 mg vs. 190.19 ± 91.83 mg, p= 0.003) and prednol dosage (94.27 ± 42.56 mg vs. 79.71 ± 18.97 mg, p= 0.020). Remifentanil administration approached statistical significance (56.99 ± 34.69 mcg vs. 45.36 ± 36.75 mcg, p= 0.055).